Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia
TOKYO & HAYWARD, Calif.--(BUSINESS WIRE)--Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Arcus Biosciences,…
Enovix Announces Completion of Warrant Dividend Program
September 05, 2025 18:08 ET | Source: Enovix Corporation Warrants Expired and…
Diginex Announces Execution of Warrants Agreement, Bonus Share Issuance and Cancelation of EGM
July 25, 2025 20:00 ET | Source: Diginex Limited LONDON, July 25,…
Xilio Therapeutics Announces Closing of $50.0 Million Public Offering
June 05, 2025 18:38 ET | Source: Xilio Therapeutics, Inc. Total gross…